BIOVERATIV INC. Comprehensive Income
BIOVERATIV INC. reported Comprehensive Income of $353.80 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2018-02-14
- BIOVERATIV INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-12-31 was $141.60M, a 37.46% decline year-over-year.
- BIOVERATIV INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-09-30 was $68.30M, a 15.16% decline year-over-year.
- BIOVERATIV INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-06-30 was $77.10M, a 16.64% increase year-over-year.
- BIOVERATIV INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-03-31 was $66.80M, a 1.91% decline year-over-year.
- BIOVERATIV INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was $353.80M, a 19.79% decline from fiscal 2016.
- BIOVERATIV INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was $441.10M, a 306.92% increase from fiscal 2015.
- BIOVERATIV INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2015 was $108.40M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2017-12-31 | $141.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $209.90M derived: sum of 2 quarters · filed 2018-02-14 | $287.00M derived: sum of 3 quarters · filed 2018-02-14 | $353.80M 10-K · filed 2018-02-14 |
| 2017-09-30 | $68.30M 10-Q · filed 2017-10-27 | $145.40M derived: sum of 2 quarters · filed 2017-10-27 | $212.20M 10-Q · filed 2017-10-27 | $438.60M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-06-30 | $77.10M 10-Q · filed 2017-08-03 | $143.90M 10-Q · filed 2017-08-03 | $370.30M derived: sum of 3 quarters · filed 2018-02-14 | $450.80M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-03-31 | $66.80M 10-Q · filed 2017-05-12 | $293.20M derived: sum of 2 quarters · filed 2018-02-14 | $373.70M derived: sum of 3 quarters · filed 2018-02-14 | $439.80M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | $226.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $306.90M derived: sum of 2 quarters · filed 2018-02-14 | $373.00M derived: sum of 3 quarters · filed 2018-02-14 | $441.10M 10-K · filed 2018-02-14 |
| 2016-09-30 | $80.50M 10-Q · filed 2017-10-27 | $146.60M derived: sum of 2 quarters · filed 2017-10-27 | $214.70M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $66.10M 10-Q · filed 2017-08-03 | $134.20M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $68.10M 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | $108.40M 10-K · filed 2018-02-14 |